Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis
- PMID: 35938455
- DOI: 10.1111/myc.13515
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis
Abstract
Background: The Fungal Infections Definitions in Intensive Care Unit (ICU) patients (FUNDICU) project aims to provide standard sets of definitions for invasive fungal diseases in critically ill, adult patients.
Objectives: To summarise the available evidence on the diagnostic performance of clinical scores and laboratory tests for invasive candidiasis (IC) in nonneutropenic, adult critically ill patients.
Methods: A systematic review was performed to evaluate studies assessing the diagnostic performance for IC of clinical scores and/or laboratory tests vs. a reference standard or a reference definition in critically ill, nonneutropenic, adult patients in ICU.
Results: Clinical scores, despite the heterogeneity of study populations and IC prevalences, constantly showed a high negative predictive value (NPV) and a low positive predictive value (PPV) for the diagnosis of IC in the target population. Fungal antigen-based biomarkers (with most studies assessing serum beta-D-glucan) retained a high NPV similar to that of clinical scores, with a higher PPV, although the latter showed important heterogeneity across studies, possibly reflecting the targeted or untargeted use of these tests in patients with a consistent clinical picture and risk factors for IC.
Conclusions: Both clinical scores and laboratory tests showed high NPV for the diagnosis of IC in nonneutropenic critically ill patients. The PPV of laboratory tests varies significantly according to the baseline patients' risk of IC. This qualitative synthesis will provide the FUNDICU panel with baseline evidence to be considered during the development of definitions of IC in critically ill, nonneutropenic adult patients in ICU.
Keywords: Candida; biomarker; candidaemia; deep-seated candidiasis; diagnosis; invasive candidiasis.
© 2022 Wiley-VCH GmbH.
Similar articles
-
Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit.Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD010754. doi: 10.1002/14651858.CD010754.pub2. Cochrane Database Syst Rev. 2018. PMID: 29582429 Free PMC article.
-
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.Intensive Care Med. 2017 Sep;43(9):1225-1238. doi: 10.1007/s00134-017-4731-2. Epub 2017 Mar 2. Intensive Care Med. 2017. PMID: 28255613
-
The measurement and monitoring of surgical adverse events.Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220. Health Technol Assess. 2001. PMID: 11532239
-
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004920. doi: 10.1002/14651858.CD004920.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2016 Jan 16;(1):CD004920. doi: 10.1002/14651858.CD004920.pub3. PMID: 16437504 Updated.
-
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.J Antimicrob Chemother. 2006 Apr;57(4):628-38. doi: 10.1093/jac/dki491. Epub 2006 Feb 3. J Antimicrob Chemother. 2006. PMID: 16459344
Cited by
-
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.Intensive Care Med. 2024 Apr;50(4):502-515. doi: 10.1007/s00134-024-07341-7. Epub 2024 Mar 21. Intensive Care Med. 2024. PMID: 38512399 Free PMC article.
-
Invasive candidiasis.Nat Rev Dis Primers. 2024 Mar 21;10(1):20. doi: 10.1038/s41572-024-00503-3. Nat Rev Dis Primers. 2024. PMID: 38514673 Review.
-
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit.J Fungi (Basel). 2022 Aug 30;8(9):921. doi: 10.3390/jof8090921. J Fungi (Basel). 2022. PMID: 36135645 Free PMC article.
-
A Narrative Review of Invasive Candidiasis in the Intensive Care Unit.Ther Adv Pulm Crit Care Med. 2024 Dec 12;19:29768675241304684. doi: 10.1177/29768675241304684. eCollection 2024 Jan-Dec. Ther Adv Pulm Crit Care Med. 2024. PMID: 39748830 Free PMC article. Review.
-
Advancing understanding and management of invasive fungal diseases in the intensive care unit: Insights from FUNDICU consensus definitions.J Intensive Med. 2024 Jul 12;4(4):482-483. doi: 10.1016/j.jointm.2024.06.001. eCollection 2024 Oct. J Intensive Med. 2024. PMID: 39310057 Free PMC article. No abstract available.
References
REFERENCES
-
- Bassetti M, Giacobbe DR, Vena A, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019;23(1):219.
-
- Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014;5(1):161-169.
-
- Ostrosky-Zeichner L, Al-Obaidi M. Invasive fungal infections in the intensive care unit. Infect Dis Clin North Am. 2017;31(3):475-487.
-
- Bassetti M, Righi E, Ansaldi F, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014;40(6):839-845.
-
- Bassetti M, Vena A, Meroi M, et al. Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts. Crit Care. 2020;24(1):117.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources